Status:
COMPLETED
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
8-14 years
Phase:
PHASE2
Brief Summary
Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Aged 8 to 14 years at the time of enrollment.
- Healthy male or female subjects
- Negative urine pregnancy test for female subjects
Exclusion
- Exclusion Criteria
- Prior vaccination with a meningococcal B vaccine
- Prior meningococcal disease
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT00387725
Start Date
November 1 2006
End Date
February 1 2008
Last Update
November 21 2014
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Sydney Children's Hospital
Randwick, New South Wales, Australia, 2031
2
The Children's Hospital at Westmead
Westmead, New South Wales, Australia, 2145
3
Royal Children's Hospital
Herston, Queensland, Australia, 4006
4
Princess Margaret Hospital for Children
Subiaco, Western Australia, Australia, 6008